header logo image


Page 529«..1020..528529530531..540550..»

Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year? – Yahoo Finance

June 13th, 2020 12:45 pm

Investors focused on the Medical space have likely heard of Applied Genetic Technologies (AGTC), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of AGTC and the rest of the Medical group's stocks.

Applied Genetic Technologies is one of 888 companies in the Medical group. The Medical group currently sits at #1 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. AGTC is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for AGTC's full-year earnings has moved 11.64% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Our latest available data shows that AGTC has returned about 15.71% since the start of the calendar year. At the same time, Medical stocks have gained an average of 0.21%. This means that Applied Genetic Technologies is outperforming the sector as a whole this year.

Looking more specifically, AGTC belongs to the Medical - Biomedical and Genetics industry, which includes 382 individual stocks and currently sits at #34 in the Zacks Industry Rank. This group has gained an average of 8.10% so far this year, so AGTC is performing better in this area.

AGTC will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportApplied Genetic Technologies Corporation (AGTC) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research

Continued here:
Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Read More...

Human Embryonic Stem Cell Market Research Explores The Key Success Factors, And Business Opportunities Including Key Players Forecast Till 2027 -…

June 13th, 2020 12:44 pm

The human embryonic stem cells are obtained from the undifferentiated inner mass cell of the human embryo and human fetal tissue. The human embryonic stem cell can replicate indefinitely and produce non-regenerative tissue such as myocardial and neural cells. This potential of human embryonic stem cell allows them to provide an unlimited amount of tissue for transplantation therapies to treat a wide range of degenerative diseases. Hence, human embryonic stem cells are used in the treatment of various diseases such as Alzheimers disease, cancer, blood and genetic disorders related to the immune system and others.

This report on Human Embryonic Stem Cell Market delivers an in-depth analysis that also comprises an elaborate assessment of this business. Also, segments of the Human Embryonic Stem Cell Market have been evidently elucidated in this study, in addition to a basic overview pertaining to the markets current status as well as size, with respect to the profit and volume parameters. The study is ubiquitous of the major insights related to the regional spectrum of this vertical as well as the companies that have effectively gained a commendable status in the Human Embryonic Stem Cell Market.

Get Sample PDF of Human Embryonic Stem Cell Market @https://www.theinsightpartners.com/sample/TIPRE00005165/

Major Players Included in this report are as follows

Human Embryonic Stem Cell Market: Regional analysis includes:

The Human Embryonic Stem Cell Market research covers an exhaustive analysis of the following data:

Historical and future growth of the global Human Embryonic Stem Cell market.

Segmentation of the Human Embryonic Stem Cell market to highlight the growth prospects and trends impacting these segments.

Changing consumption behavior of customers across various regions.

Regional analysis on the basis of market share, growth outlook, and key countries.

Agreements, product launches, acquisitions, and R&D projects of different Human Embryonic Stem Cell market players.

The Human Embryonic Stem Cell market research addresses critical questions, such as

Why is region surpassing region in terms of value by the end of 2027?

How are the consumers using Human Embryonic Stem Cell for various purposes?

Which players are entering into collaborations in the market of the Human Embryonic Stem Cell ?

At what rate has the global Human Embryonic Stem Cell market been growing throughout the historic period?

In terms of value, which segment holds the largest share?

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure @https://www.theinsightpartners.com/buy/TIPRE00005165/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email:[emailprotected]

See the article here:
Human Embryonic Stem Cell Market Research Explores The Key Success Factors, And Business Opportunities Including Key Players Forecast Till 2027 -...

Read More...

COVID-19: Potential impact on Animal Stem Cell Therapy Market top key players, size, Analysis, growth, research, Types, Regions and Forecast from…

June 13th, 2020 12:44 pm

The report on the Animal Stem Cell Therapy market provides a birds eye view of the current proceeding within the Animal Stem Cell Therapy market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Animal Stem Cell Therapy market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Animal Stem Cell Therapy market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

As per the presented market report, the global Animal Stem Cell Therapy market is projected to attain a CAGR growth of ~XX% during the assessment period and surpass a value of ~US$XX by the end of 20XX. Further, the report suggests that the growth of the Animal Stem Cell Therapy market hinges its hope on a range of factors including, emphasis on innovation by market players, surge in the investments pertaining to R&D activities, and favorable regulatory policies among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2638488&source=atm

Competition Landscape

The report provides critical insights related to the business operations of prominent companies operating in the Animal Stem Cell Therapy market. The revenue generated, market presence of different companies, product range, and the financials of each company is included in the report.

Regional Landscape

The regional landscape section of the report provides resourceful insights related to the scenario of the Animal Stem Cell Therapy market in the key regions. Further, the market attractiveness of each region provides players a clear understanding of the overall growth potential of the Animal Stem Cell Therapy market in each region.

End-User Analysis

The report provides a detailed analysis of the various end-users of the Animal Stem Cell Therapy along with the market share, size, and revenue generated by each end-user.

Segment by Type, the Animal Stem Cell Therapy market is segmented intoDogsHorsesOthers

Segment by Application, the Animal Stem Cell Therapy market is segmented intoVeterinary HospitalsResearch Organizations

Regional and Country-level AnalysisThe Animal Stem Cell Therapy market is analysed and market size information is provided by regions (countries).The key regions covered in the Animal Stem Cell Therapy market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and Animal Stem Cell Therapy Market Share AnalysisAnimal Stem Cell Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Stem Cell Therapy business, the date to enter into the Animal Stem Cell Therapy market, Animal Stem Cell Therapy product introduction, recent developments, etc.The major vendors covered:Medivet Biologics LLCVETSTEM BIOPHARMAJ-ARMU.S. Stem Cell, IncVetCell TherapeuticsCelavet Inc.Magellan Stem CellsKintaro Cells PowerAnimal Stem CareAnimal Cell TherapiesCell Therapy SciencesAnimacel

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2638488&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2638488&licType=S&source=atm

Original post:
COVID-19: Potential impact on Animal Stem Cell Therapy Market top key players, size, Analysis, growth, research, Types, Regions and Forecast from...

Read More...

Global Cell Isolation Technology Market 2020 Competition Landscape and Growth Opportunity, Industry Status and Forecast 2025 – Jewish Life News

June 13th, 2020 12:44 pm

Global Cell Isolation Technology Market Growth (Status and Outlook) 2020-2025 organized by researchers atMarketsandResearch.bizpresents a detailed diagram of the market in terms of current and future trends driving the profit pattern. The report includes informative data figures and key insights regarding the market components such as market size, market share, market segmentation, significant growth drivers, and market competition. The report outlines expected business up-downs, different aspects impacting economic cycles in the market, demand, changing customer sentiments, key companies operating in the global Cell Isolation Technology market, and regional landscape with the help of statistics, diagrams, charts, and graphs. It provides a SWOT analysis of the competitive landscape of the market.

Then the report covers factors such as industry value chain, key consumption trends, recent patterns of customer behaviors, overall spending capacity analysis, market expansion rate, etc. This study categorizes the global Cell Isolation Technology breakdown data by manufacturers, region, type, and applications, also analyzes the market drivers, opportunities, and challenges. There is a section featuring the essential data gathered through Industry specialists and key authorities of profiled organizations. Leading players are considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.

NOTE:This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Cell Isolation Technology market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/59723

Key manufacturers analysis: Thermo Fisher Scientific, Inc., Merck, Beckman Coulter, Inc., Terumo BCT, BD Biosciences, Bio-Rad Laboratories, Inc., GE Healthcare, Stemcell Technologies,

On the basis of product types, the global market is classified into: Centrifugation, Flow Cytometry, Cell Electrophoresis,

On the basis of end-users, the global market is classified into: Stem cell research, Cancer research, Tissue regeneration, In-vitro diagnostics, Other

This Report Enfolds Following Market Aspects:

Key players strategic initiatives and competitive developments such as joint ventures, mergers, and new product launches in the market are taken into consideration. Cell Isolation Technology providers, research and consulting firms, government and research organizations, and associations and industry bodies are the target audiences of this market research report. Forecast estimates are given for regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end-use industry trends and dynamics, and capacity.

The global Cell Isolation Technology market report also analyzes the major geographic regions as well as the major countries in these regions. The regions and countries covered in the study include: Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/59723/global-cell-isolation-technology-market-growth-status-and-outlook-2020-2025

Report Answers Following Questions:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone:+1-201-465-4211Email:[emailprotected]Web:www.marketsandresearch.biz

Read this article:
Global Cell Isolation Technology Market 2020 Competition Landscape and Growth Opportunity, Industry Status and Forecast 2025 - Jewish Life News

Read More...

Coronavirus (COVID-19) Business Impact Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market 2019 Analysis by Key Players, Share, Trend,…

June 13th, 2020 12:44 pm

Detailed Study on the Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market

A recent market study throws light on some of the leading factors that are likely to influence the growth of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market in the upcoming decade. The well-researched market study touches upon the growth potential of various budding market players in the current Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market landscape. Moreover, established players, stakeholders, and investors can leverage the data in the report to formulate effective growth strategies.

As per the report, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is forecasted to reach a value of ~US$XX by the end of 2029 and grow at a CAGR of ~XX% through the forecast period (2019-2029). The key dynamics of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market including the drivers, restraints, opportunities, and trends are thoroughly analyzed in the presented report.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2650584&source=atm

The Research Aims to Addresses the Following Doubts Pertaining to the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market

The report on the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market provides a birds eye view of the current proceeding within the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2650584&source=atm

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segmentation

Competitive Landscape

The competitive landscape section of the report elaborates on the recent developments and innovations introduced by prominent players in the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market. The growth potential, revenue growth, product range, and pricing strategies of each market player in inspected in the report with precision.

End-use Industry Assessment

The report segments the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market on the basis of end-use industry and offers a detailed understanding of the supply-demand ratio and consumption pattern of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in each end-use industry.

Regional and Country-level AnalysisThe report offers an exhaustive geographical analysis of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.Competition AnalysisIn the competitive analysis section of the report, leading as well as prominent players of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market.The following players are covered in this report:JanssenQiagenAdvanced Cell DiagnosticsApoCellBiofluidicaClearbridge BiomedicsCytoTrackCelseeFluxionGilupiCynvenioOn-chipYZY BioBioViewFluidigmIkonisysAdnaGenIVDiagnosticsMiltenyi BiotecScreenCellSilicon BiosystemsCirculating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by TypeCellSearchOthersCirculating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by ApplicationBreast Cancer Diagnosis and TreatmentProstate Cancer Diagnosis and TreatmentColorectal Cancer Diagnosis and TreatmentLung Cancer Diagnosis and TreatmentOther Cancers Diagnosis and Treatment

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2650584&licType=S&source=atm

Essential Findings of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report:

Continued here:
Coronavirus (COVID-19) Business Impact Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market 2019 Analysis by Key Players, Share, Trend,...

Read More...

Cell Proliferation Kit Market Competitive Analysis, Demand and Outlook 2020 to 2025 – Cole of Duty

June 13th, 2020 12:44 pm

The global Cell Proliferation Kit Market 2020 Research report provides information regarding market size, share, trends, growth, cost structure, global market competition landscape, market drivers, challenges and opportunity, capacity, revenue and forecast 2024. This report also includes the overall and comprehensive study of the Cell Proliferation Kit market with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Cell Proliferation Kit industry and provides data for making strategies to increase the market growth and effectiveness.

Click the link to get a Sample Copy of the Report:https://www.marketinsightsreports.com/reports/02101828190/global-cell-proliferation-kit-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025/inquiry?Source=COLEOFDUTY&Mode=SK48

Top Companies in the Global Cell Proliferation Kit Market: Biological Industries, Bio-Rad, BD Biosciences, Thermo Fisher Scientific, Millipoore (Merck), Sigma-Aldrich (Merck), Mindray Medical, PerkinElmer, GE Healthcare, Biotium and others

Cell proliferation kit is a test that provides rapid and deep quantification of cell proliferation and survival. This test is based on the division of tetrazolium salt WST-1 to formazan by cellular mitochondrial dehydrogenases. The increase in the number of viable cells can be determined by the amount of formazan dye produced by the reaction. Cell proliferation kits were used for analysis of toxic agents, pharmaceutical compounds, and quantification of cell proliferation with respect to growth factors, nutrients, and mitogens.

This report segments the Cell Proliferation Kit market on the basis of Types is:Colorimetric Detection MethodFluorescent Detection MethodOther

On the basis of Application, the Cell Proliferation Kit market is segmented into:ClinicalIndustrial & Applied ScienceStem Cell Research

Avail Exclusive Discount on this: (FLAT 30% OFF) https://www.marketinsightsreports.com/reports/02101828190/global-cell-proliferation-kit-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025/discount?Source=COLEOFDUTY&Mode=SK48

Regional Analysis For Cell Proliferation Kit Market:For comprehensive understanding of market dynamics, the global Cell Proliferation Kit market is analyzed across key geographies namely: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

Crucial Elements from the Table of Contents of Global Cell Proliferation Kit Market:

Cell Proliferation Kit Market Overview

Global Cell Proliferation Kit Market Competition, Profiles/Analysis, Strategies

Global Cell Proliferation Kit Capacity, Production, Revenue (Value) by Region (2014-2019)

Global Cell Proliferation Kit Supply (Production), Consumption, Export, Import by Region (2014-2019)

Global Cell Proliferation Kit Market Regional Highlights

Industrial Chain, Sourcing Strategy and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Market Decisions with respect to present scenario

Global Cell Proliferation Kit Market Forecast (2020-2025)

Case Studies

Research Findings and Conclusion

Highlights the following key factors: Business description: A detailed description of the companys operations and business divisions. Corporate strategy: Analysts summarization of the companys business strategy. SWOT Analysis: A detailed analysis of the companys strengths, weaknesses, opportunities, and threats. Company history: Progression of key events associated with the company. Major products and services: A list of major products, services, and brands of the company. Key competitors: A list of key competitors to the company. Important locations and subsidiaries: A list and contact details of key locations and subsidiaries of the company. Detailed financial ratios for the past five years: The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Browse the full report description and TOC:https://www.marketinsightsreports.com/reports/02101828190/global-cell-proliferation-kit-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025?Source=COLEOFDUTY&Mode=SK48

We Offer Customization on report based on specific client Requirement: Free country Level analysis for any 5 countries of your choice. Free Competitive analysis of any 5 key market players. Free 40 analyst hours to cover any other data point.

About Us: MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:Irfan Tamboli (Head of Sales) Market Insights Reports[emailprotected]|[emailprotected]Phone: + 1704 266 3234 | +91-750-707-8687

See the original post:
Cell Proliferation Kit Market Competitive Analysis, Demand and Outlook 2020 to 2025 - Cole of Duty

Read More...

Potential Impact of COVID-19 on Research report explores the Cell Culture Supporting Instrument Market for the forecast period, 2019-2027 – Farmers…

June 13th, 2020 12:44 pm

The Cell Culture Supporting Instrument market research encompasses an exhaustive analysis of the market outlook, framework, and socio-economic impacts. The report covers the accurate investigation of the market size, share, product footprint, revenue, and progress rate. Driven by primary and secondary researches, the Cell Culture Supporting Instrument market study offers reliable and authentic projections regarding the technical jargon.All the players running in the global Cell Culture Supporting Instrument market are elaborated thoroughly in the Cell Culture Supporting Instrument market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the Cell Culture Supporting Instrument market players.The report on the Cell Culture Supporting Instrument market provides a birds eye view of the current proceeding within the Cell Culture Supporting Instrument market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Cell Culture Supporting Instrument market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2633694&source=atm

Market Segment AnalysisThe research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.Segment by TypeCell CountersFiltration SystemsCentrifugesCO2 IncubatorsAutoclavesMicroscopesBiosafety CabinetsOthers

Segment by ApplicationBiopharmaceutical/TherapeuticsStem Cell TechnologyCancer ResearchDrug Screening & DevelopmentTissue Engineering & Regenerative MedicineOthers

Global Cell Culture Supporting Instrument Market: Regional AnalysisThe report offers in-depth assessment of the growth and other aspects of the Cell Culture Supporting Instrument market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.Global Cell Culture Supporting Instrument Market: Competitive LandscapeThis section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.The major players in the market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (U.K.), Lonza Group AG (Switzerland), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), Eppendorf AG (Germany), Hi-Media Laboratories (India), Sartorius AG (Germany), Promocell GmbH (Germany), etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2633694&source=atm

Objectives of the Cell Culture Supporting Instrument Market Study:To define, describe, and analyze the global Cell Culture Supporting Instrument market based on oil type, product type, ship type, and regionTo forecast and analyze the Cell Culture Supporting Instrument market size (in terms of value and volume) and submarkets in 5 regions, namely, APAC, Europe, North America, Central & South America, and the Middle East & AfricaTo forecast and analyze the Cell Culture Supporting Instrument market at country-level for each regionTo strategically analyze each submarket with respect to individual growth trends and their contribution to the global Cell Culture Supporting Instrument marketTo analyze opportunities in the market for stakeholders by identifying high growth segments of the global Cell Culture Supporting Instrument marketTo identify trends and factors driving or inhibiting the growth of the market and submarketsTo analyze competitive developments, such as expansions and new product launches, in the global Cell Culture Supporting Instrument marketTo strategically profile key market players and comprehensively analyze their growth strategiesThe Cell Culture Supporting Instrument market research focuses on the market structure and various factors (positive and negative) affecting the growth of the market. The study encloses a precise evaluation of the Cell Culture Supporting Instrument market, including growth rate, current scenario, and volume inflation prospects, on the basis of DROT and Porters Five Forces analyses. In addition, the Cell Culture Supporting Instrument market study provides reliable and authentic projections regarding the technical jargon.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2633694&licType=S&source=atm

After reading the Cell Culture Supporting Instrument market report, readers can:Identify the factors affecting the Cell Culture Supporting Instrument market growth drivers, restraints, opportunities and trends.Examine the Y-o-Y growth of the global Cell Culture Supporting Instrument market.Analyze trends impacting the demand prospect for the Cell Culture Supporting Instrument in various regions.Recognize different tactics leveraged by players of the global Cell Culture Supporting Instrument market.Identify the Cell Culture Supporting Instrument market impact on various industries.

More:
Potential Impact of COVID-19 on Research report explores the Cell Culture Supporting Instrument Market for the forecast period, 2019-2027 - Farmers...

Read More...

Global trade impact of the Coronavirus Stem Cell Media Market 2019 Demand, Segments, Trends, Future-Growth, Business-Opportunities, Share,…

June 13th, 2020 12:44 pm

The report on the Stem Cell Media market provides a birds eye view of the current proceeding within the Stem Cell Media market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Stem Cell Media market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Stem Cell Media market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

The recent published research report sheds light on critical aspects of the global Stem Cell Media market such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report helps the readers to draw a suitable conclusion and clearly understand the current and future scenario and trends of global Stem Cell Media market. The research study comes out as a compilation of useful guidelines for players to understand and define their strategies more efficiently in order to keep themselves ahead of their competitors. The report profiles leading companies of the global Stem Cell Media market along with the emerging new ventures who are creating an impact on the global market with their latest innovations and technologies.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2643271&source=atm

The recent published study includes information on key segmentation of the global Stem Cell Media market on the basis of type/product, application and geography (country/region). Each of the segments included in the report is studies in relations to different factors such as market size, market share, value, growth rate and other quantitate information.

The competitive analysis included in the global Stem Cell Media market study allows their readers to understand the difference between players and how they are operating amounts themselves on global scale. The research study gives a deep insight on the current and future trends of the market along with the opportunities for the new players who are in process of entering global Stem Cell Media market. Market dynamic analysis such as market drivers, market restraints are explained thoroughly in the most detailed and easiest possible manner. The companies can also find several recommendations improve their business on the global scale.

The readers of the Stem Cell Media Market report can also extract several key insights such as market size of varies products and application along with their market share and growth rate. The report also includes information for next five years as forested data and past five years as historical data and the market share of the several key information.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2643271&source=atm

Global Stem Cell Media Market by Companies:

The company profile section of the report offers great insights such as market revenue and market share of global Stem Cell Media market. Key companies listed in the report are:

Competition AnalysisIn the competitive analysis section of the report, leading as well as prominent players of the global Stem Cell Media market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Media market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Media market.The following manufacturers are covered in this report:Thermo FisherSTEMCELL TechnologiesMerck MilliporeLonzaGE HealthcareMiltenyi BiotecCorningCellGenixTakaraPromoCellHiMediaStem Cell Media Breakdown Data by TypePluripotent Stem Cell CultureHematopoietic Stem Cell CultureMesenchymal Stem Cell CultureOthersStem Cell Media Breakdown Data by ApplicationScientific ResearchIndustrial Production

Global Stem Cell Media Market by Geography:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2643271&licType=S&source=atm

Some of the Major Highlights of TOC covers in Stem Cell Media Market Report:

Chapter 1: Methodology & Scope of Stem Cell Media Market

Chapter 2: Executive Summary of Stem Cell Media Market

Chapter 3: Stem Cell Media Industry Insights

Chapter 4: Stem Cell Media Market, By Region

Chapter 5: Company Profile

And Continue

More here:
Global trade impact of the Coronavirus Stem Cell Media Market 2019 Demand, Segments, Trends, Future-Growth, Business-Opportunities, Share,...

Read More...

COVID-19 Impact and Recovery Analysis- Stem Cell Banking Market | Growth & Forecast to 2020 – Cole of Duty

June 13th, 2020 12:44 pm

Stem Cell Banking Market valued $XX million in 2019 and is poised to expand with a CAGR of X.X% during the forecast period to reach a market value of $XX million by the end of 2026.

Request a Free Sample Report @ https://www.reportengines.com/market-research/stem-cell-banking-market-12268/request-sample

Stem Cell Banking Market Key PlayersCCBCCrioestaminalEsperiteCBRLifeCellViaCordCordlifeBoyalifeVcanbioRMS RegrowCryo-cellAmericordPBKM FamiCordFamilycordCellsafe BiotechStemCytecells4lifeKrioPacifiCordBeikebiotechCryo StemcellStemade Biotech

The Stem Cell Banking market report an extensive study of product, application, end users and regions in Stem Cell Banking market worldwide. The report offer global, regional and country level analysis of all market segments with qualitative analysis including market driving forces, growth restraining factors, market trend and growth opportunity analysis. Moreover, the qualitative analysis is supported with facts and figures which sheds light on quantitative aspect of the market.The report provides Stem Cell Banking market value for prominent product and services categories along with their application in various field of the industry. For each segment the report provides market value in terms of USD million for historical period 2016-2019 and future market projections for forecast period 2020-2026.

Browse More Details at: https://www.reportengines.com/market-research/stem-cell-banking-market-12268

The report further dives into regional Stem Cell Banking market where it brings geographic market scenario on surface. The report only provides total regional and country market numbers, but also offers product and application market figures in each country across major regional market. This puts forth a comprehensive perspective of market highlighting fasting growth regional and country level market, fastest growing product market in a particular regions/ country and also present comparative analysis of regional markets Stem Cell Banking products. Stem Cell Banking Market Segmentation:

The Stem Cell Banking market report is segmented into following categories;

By TypeUmbilical Cord Blood Stem CellEmbryonic Stem CellAdult Stem CellOthers

By ApplicationDiseases TherapyHealthcare

Request for Report Customization @ https://www.reportengines.com/market-research/stem-cell-banking-market-12268/customization-form

Above segments market information will be covered for following regions North AmericaThe U.S.CanadaMexicoEuropeGermanyFranceUKItalySpainRussiaAsia PacificChinaJapanIndiaSouth KoreaAustraliaMiddle East and AfricaSaudi ArabiaUAESouth AfricaSouth AmericaBrazilArgentina

Contact USReport EnginesE-mail: [emailprotected]Tel: +1-816-301-6258Web: https://www.reportengines.com/Address:107 W. 9th Street, 2nd Floor, Kansas City, Missouri, 64105, United States of America

About UsReport Engines is a market research firm operating in business to business and business to customer research. The company provides qualitative and quantitative market research reports covering all major industry domains ranging from technology to manufacturing industry. Our market research expertise are in healthcare, automotive, food and beverages, telecom and IT, energy and power, etc.

Read the original post:
COVID-19 Impact and Recovery Analysis- Stem Cell Banking Market | Growth & Forecast to 2020 - Cole of Duty

Read More...

Trending: Progenitor Cell Product Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026 – Weekly Wall

June 13th, 2020 12:44 pm

LOS ANGELES, United States: QY Research has recently published a report, titled COVID-19 Impact on Global Progenitor Cell Product, Market Insights and Forecast to 2026.The market research report is a brilliant, and much-needed resource for companies, stakeholders, and investors interested in the global COVID-19 Impact on Progenitor Cell Product market. It informs readers about key trends and opportunities in the global COVID-19 Impact on Progenitor Cell Product market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global COVID-19 Impact on Progenitor Cell Product market.

Key companies operating in the global COVID-19 Impact on Progenitor Cell Product market include , NeuroNova AB, StemCells, ReNeuron Limited, Asterias Biotherapeutics, Thermo Fisher Scientific, STEMCELL Technologies, Axol Bio, R&D Systems, Lonza, ATCC, Irvine Scientific, CDI Progenitor Cell Product

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1823823/covid-19-impact-on-global-progenitor-cell-product-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global COVID-19 Impact on Progenitor Cell Product market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global COVID-19 Impact on Progenitor Cell Product Market Segment By Type:

, Pancreatic progenitor cells, Cardiac Progenitor Cells, Intermediate progenitor cells, Neural progenitor cells (NPCs), Endothelial progenitor cells (EPC), Others Progenitor Cell Product

Global COVID-19 Impact on Progenitor Cell Product Market Segment By Application:

, Medical care, Hospital, Laboratory

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global COVID-19 Impact on Progenitor Cell Product market.

Key companies operating in the global COVID-19 Impact on Progenitor Cell Product market include , NeuroNova AB, StemCells, ReNeuron Limited, Asterias Biotherapeutics, Thermo Fisher Scientific, STEMCELL Technologies, Axol Bio, R&D Systems, Lonza, ATCC, Irvine Scientific, CDI Progenitor Cell Product

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1823823/covid-19-impact-on-global-progenitor-cell-product-market

TOC

1 Study Coverage1.1 Progenitor Cell Product Product Introduction1.2 Market Segments1.3 Key Progenitor Cell Product Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global Progenitor Cell Product Market Size Growth Rate by Type1.4.2 Pancreatic progenitor cells1.4.3 Cardiac Progenitor Cells1.4.4 Intermediate progenitor cells1.4.5 Neural progenitor cells (NPCs)1.4.6 Endothelial progenitor cells (EPC)1.4.7 Others1.5 Market by Application1.5.1 Global Progenitor Cell Product Market Size Growth Rate by Application1.5.2 Medical care1.5.3 Hospital1.5.4 Laboratory1.6 Coronavirus Disease 2019 (Covid-19): Progenitor Cell Product Industry Impact1.6.1 How the Covid-19 is Affecting the Progenitor Cell Product Industry 1.6.1.1 Progenitor Cell Product Business Impact Assessment Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Progenitor Cell Product Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Progenitor Cell Product Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Executive Summary2.1 Global Progenitor Cell Product Market Size Estimates and Forecasts2.1.1 Global Progenitor Cell Product Revenue 2015-20262.1.2 Global Progenitor Cell Product Sales 2015-20262.2 Progenitor Cell Product Market Size by Region: 2020 Versus 20262.2.1 Global Progenitor Cell Product Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Progenitor Cell Product Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Progenitor Cell Product Competitor Landscape by Players3.1 Progenitor Cell Product Sales by Manufacturers3.1.1 Progenitor Cell Product Sales by Manufacturers (2015-2020)3.1.2 Progenitor Cell Product Sales Market Share by Manufacturers (2015-2020)3.2 Progenitor Cell Product Revenue by Manufacturers3.2.1 Progenitor Cell Product Revenue by Manufacturers (2015-2020)3.2.2 Progenitor Cell Product Revenue Share by Manufacturers (2015-2020)3.2.3 Global Progenitor Cell Product Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Progenitor Cell Product Revenue in 20193.2.5 Global Progenitor Cell Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Progenitor Cell Product Price by Manufacturers3.4 Progenitor Cell Product Manufacturing Base Distribution, Product Types3.4.1 Progenitor Cell Product Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Progenitor Cell Product Product Type3.4.3 Date of International Manufacturers Enter into Progenitor Cell Product Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Progenitor Cell Product Market Size by Type (2015-2020)4.1.1 Global Progenitor Cell Product Sales by Type (2015-2020)4.1.2 Global Progenitor Cell Product Revenue by Type (2015-2020)4.1.3 Progenitor Cell Product Average Selling Price (ASP) by Type (2015-2026)4.2 Global Progenitor Cell Product Market Size Forecast by Type (2021-2026)4.2.1 Global Progenitor Cell Product Sales Forecast by Type (2021-2026)4.2.2 Global Progenitor Cell Product Revenue Forecast by Type (2021-2026)4.2.3 Progenitor Cell Product Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Progenitor Cell Product Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026)5.1 Global Progenitor Cell Product Market Size by Application (2015-2020)5.1.1 Global Progenitor Cell Product Sales by Application (2015-2020)5.1.2 Global Progenitor Cell Product Revenue by Application (2015-2020)5.1.3 Progenitor Cell Product Price by Application (2015-2020)5.2 Progenitor Cell Product Market Size Forecast by Application (2021-2026)5.2.1 Global Progenitor Cell Product Sales Forecast by Application (2021-2026)5.2.2 Global Progenitor Cell Product Revenue Forecast by Application (2021-2026)5.2.3 Global Progenitor Cell Product Price Forecast by Application (2021-2026) 6 North America6.1 North America Progenitor Cell Product by Country6.1.1 North America Progenitor Cell Product Sales by Country6.1.2 North America Progenitor Cell Product Revenue by Country6.1.3 U.S.6.1.4 Canada6.2 North America Progenitor Cell Product Market Facts & Figures by Type6.3 North America Progenitor Cell Product Market Facts & Figures by Application 7 Europe7.1 Europe Progenitor Cell Product by Country7.1.1 Europe Progenitor Cell Product Sales by Country7.1.2 Europe Progenitor Cell Product Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia7.2 Europe Progenitor Cell Product Market Facts & Figures by Type7.3 Europe Progenitor Cell Product Market Facts & Figures by Application 8 Asia Pacific8.1 Asia Pacific Progenitor Cell Product by Region8.1.1 Asia Pacific Progenitor Cell Product Sales by Region8.1.2 Asia Pacific Progenitor Cell Product Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam8.2 Asia Pacific Progenitor Cell Product Market Facts & Figures by Type8.3 Asia Pacific Progenitor Cell Product Market Facts & Figures by Application 9 Latin America9.1 Latin America Progenitor Cell Product by Country9.1.1 Latin America Progenitor Cell Product Sales by Country9.1.2 Latin America Progenitor Cell Product Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina9.2 Central & South America Progenitor Cell Product Market Facts & Figures by Type9.3 Central & South America Progenitor Cell Product Market Facts & Figures by Application 10 Middle East and Africa10.1 Middle East and Africa Progenitor Cell Product by Country10.1.1 Middle East and Africa Progenitor Cell Product Sales by Country10.1.2 Middle East and Africa Progenitor Cell Product Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 U.A.E10.2 Middle East and Africa Progenitor Cell Product Market Facts & Figures by Type10.3 Middle East and Africa Progenitor Cell Product Market Facts & Figures by Application 11 Company Profiles11.1 NeuroNova AB11.1.1 NeuroNova AB Corporation Information11.1.2 NeuroNova AB Description, Business Overview and Total Revenue11.1.3 NeuroNova AB Sales, Revenue and Gross Margin (2015-2020)11.1.4 NeuroNova AB Progenitor Cell Product Products Offered11.1.5 NeuroNova AB Recent Development11.2 StemCells11.2.1 StemCells Corporation Information11.2.2 StemCells Description, Business Overview and Total Revenue11.2.3 StemCells Sales, Revenue and Gross Margin (2015-2020)11.2.4 StemCells Progenitor Cell Product Products Offered11.2.5 StemCells Recent Development11.3 ReNeuron Limited11.3.1 ReNeuron Limited Corporation Information11.3.2 ReNeuron Limited Description, Business Overview and Total Revenue11.3.3 ReNeuron Limited Sales, Revenue and Gross Margin (2015-2020)11.3.4 ReNeuron Limited Progenitor Cell Product Products Offered11.3.5 ReNeuron Limited Recent Development11.4 Asterias Biotherapeutics11.4.1 Asterias Biotherapeutics Corporation Information11.4.2 Asterias Biotherapeutics Description, Business Overview and Total Revenue11.4.3 Asterias Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)11.4.4 Asterias Biotherapeutics Progenitor Cell Product Products Offered11.4.5 Asterias Biotherapeutics Recent Development11.5 Thermo Fisher Scientific11.5.1 Thermo Fisher Scientific Corporation Information11.5.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue11.5.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)11.5.4 Thermo Fisher Scientific Progenitor Cell Product Products Offered11.5.5 Thermo Fisher Scientific Recent Development11.6 STEMCELL Technologies11.6.1 STEMCELL Technologies Corporation Information11.6.2 STEMCELL Technologies Description, Business Overview and Total Revenue11.6.3 STEMCELL Technologies Sales, Revenue and Gross Margin (2015-2020)11.6.4 STEMCELL Technologies Progenitor Cell Product Products Offered11.6.5 STEMCELL Technologies Recent Development11.7 Axol Bio11.7.1 Axol Bio Corporation Information11.7.2 Axol Bio Description, Business Overview and Total Revenue11.7.3 Axol Bio Sales, Revenue and Gross Margin (2015-2020)11.7.4 Axol Bio Progenitor Cell Product Products Offered11.7.5 Axol Bio Recent Development11.8 R&D Systems11.8.1 R&D Systems Corporation Information11.8.2 R&D Systems Description, Business Overview and Total Revenue11.8.3 R&D Systems Sales, Revenue and Gross Margin (2015-2020)11.8.4 R&D Systems Progenitor Cell Product Products Offered11.8.5 R&D Systems Recent Development11.9 Lonza11.9.1 Lonza Corporation Information11.9.2 Lonza Description, Business Overview and Total Revenue11.9.3 Lonza Sales, Revenue and Gross Margin (2015-2020)11.9.4 Lonza Progenitor Cell Product Products Offered11.9.5 Lonza Recent Development11.10 ATCC11.10.1 ATCC Corporation Information11.10.2 ATCC Description, Business Overview and Total Revenue11.10.3 ATCC Sales, Revenue and Gross Margin (2015-2020)11.10.4 ATCC Progenitor Cell Product Products Offered11.10.5 ATCC Recent Development11.1 NeuroNova AB11.1.1 NeuroNova AB Corporation Information11.1.2 NeuroNova AB Description, Business Overview and Total Revenue11.1.3 NeuroNova AB Sales, Revenue and Gross Margin (2015-2020)11.1.4 NeuroNova AB Progenitor Cell Product Products Offered11.1.5 NeuroNova AB Recent Development11.12 CDI11.12.1 CDI Corporation Information11.12.2 CDI Description, Business Overview and Total Revenue11.12.3 CDI Sales, Revenue and Gross Margin (2015-2020)11.12.4 CDI Products Offered11.12.5 CDI Recent Development 12 Future Forecast by Regions (Countries) (2021-2026)12.1 Progenitor Cell Product Market Estimates and Projections by Region12.1.1 Global Progenitor Cell Product Sales Forecast by Regions 2021-202612.1.2 Global Progenitor Cell Product Revenue Forecast by Regions 2021-202612.2 North America Progenitor Cell Product Market Size Forecast (2021-2026)12.2.1 North America: Progenitor Cell Product Sales Forecast (2021-2026)12.2.2 North America: Progenitor Cell Product Revenue Forecast (2021-2026)12.2.3 North America: Progenitor Cell Product Market Size Forecast by Country (2021-2026)12.3 Europe Progenitor Cell Product Market Size Forecast (2021-2026)12.3.1 Europe: Progenitor Cell Product Sales Forecast (2021-2026)12.3.2 Europe: Progenitor Cell Product Revenue Forecast (2021-2026)12.3.3 Europe: Progenitor Cell Product Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Progenitor Cell Product Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Progenitor Cell Product Sales Forecast (2021-2026)12.4.2 Asia Pacific: Progenitor Cell Product Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Progenitor Cell Product Market Size Forecast by Region (2021-2026)12.5 Latin America Progenitor Cell Product Market Size Forecast (2021-2026)12.5.1 Latin America: Progenitor Cell Product Sales Forecast (2021-2026)12.5.2 Latin America: Progenitor Cell Product Revenue Forecast (2021-2026)12.5.3 Latin America: Progenitor Cell Product Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Progenitor Cell Product Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Progenitor Cell Product Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Progenitor Cell Product Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Progenitor Cell Product Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Progenitor Cell Product Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Progenitor Cell Product Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

More:
Trending: Progenitor Cell Product Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026 - Weekly Wall

Read More...

Blood screening Research, Opportunities, Emerging Trends, Competitive Strategies And Forecasts 2016-2028 – 3rd Watch News

June 13th, 2020 12:43 pm

A recent report published by QMI on blood screening market is a detailed assessment of the most important market dynamics. After carrying out thorough research on the market of blood screening historical as well as current growth parameters, business expectations for growth are obtained with utmost precision. The study identifies specific and important factors affecting the market for blood screening during the forecast period. It can enable manufacturers of blood screening to change their production and marketing strategies in order to envisage maximum growth. The market report on blood screening offers detailed information for stakeholders in the most comprehensive way on the current and future growth prospects of the demand for blood screening market.

To Request Sample Premium Reports: https://www.quincemarketinsights.com/request-sample-59139?utm_source=SSK&utm_medium=3WN&utm_campaign=SSK

This report provides comprehensive taxonomy and the description of industry-related products, applications and end-user channels for the blood screening market. This report also provides insight into market concepts for phase. This contains opportunity analysis which provides information on the most relevant macroeconomic and microeconomic factors affecting market revenues and estimates for the phase. The market background is discussed in the report which sheds a light on the key drivers, threats, patterns and opportunities in the demand for blood screening market. A global overview has been presented for blood screening products, supply chain analysis and hazard analysis, which is expected to help readers identify the key factors that support the growth of the demand for blood screening market. The report discusses the regulatory scenario affecting approvals for the products, across leading regions. It also provides information on the demand of the blood screening market adopted in leading countries. It includes a specific list of retailers and manufacturers dealing in blood screening market. Readers will also be able to find regional developments and regulations that impact market growth. Significant growth prospects are given for countries which also include key regional developments and factors that influence the growth of the demand for blood screening market. The report studies business patterns of top companys like- fujifilm holdings corporation, analogic corporation, siemens healthcare, esaote s.p.a, toshiba medical systems corporation, ge healthcare, philips healthcare, hitachi medical corporation, and mindray medical international ltd

Get TOC For The Overview Of The Premium Report: https://www.quincemarketinsights.com/request-toc-59139?utm_source=SSK&utm_medium=3WN&utm_campaign=SSK

Blood screening market growth is expected to gain high momentum during the forecast period due to increasing demand for imaging devices for diagnostics applications. An ceiling-mounted surgical lights is a medical imaging device, which uses high-frequency waves to visualize the internal organs of the body such as blood vessels, kidney, liver, human foetus, heart, etc. This market is gaining momentum, owing to the increase in the number of hospitals and adoption of technologically advanced devices, which can serve the purpose for both diagnostics and therapeutics. Moreover, the cumulative prevalence of cancer is driving the demand for early detections and minimization of expenses. According to the Cancer Research Institute (CRI), there were approximately 17 million new cases of cancer globally, as of 2017, which is also fuelling the demand for ultrasound devices.

Segment Analysis

The bed head multifunctional belt market has been segmented by technology (nucleic acid amplification, elisa, rapid test, western blot), by product (instrument, reagent & kits, software), by end user (blood bank, hospital). Based on portability, the market can be divided into trolley/cart and compact/handheld. Based on application, the market has been divided into radiology, gynaecology, urology, cardiology, orthopaedic/musculoskeletal, and others. Owing to the growing incidences of stem cell-based injuries and the demand for high-quality diagnostic procedures, the radiology segment is expected to lead. The market has been studied for North America, Western Europe, Eastern Europe, Asia Pacific, and Rest of the World.

Key Factors Impacting Market Growth:

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the ultrasound market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favourable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for ultrasound market during the forecast period.

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for ultrasound market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for ultrasound market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for ultrasound during the forecast period.

Speak To Analyst before Buying This: https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-59139?utm_source=SSK&utm_medium=3WN&utm_campaign=SSK

Market Segmentation:

By Technology:

North America, by Country

US

Canada

Mexico

North America, by Product

North America, by End-User

North America, by Technology

Western Europe, by Country

Germany

UK

France

Italy

Spain

The Netherlands

Rest of Western Europe

Western Europe, by Product

Western Europe, by End-User

Western Europe, by Technology

Asia Pacific, by Country

China

India

Japan

South Korea

Australia

Indonesia

Rest of Asia Pacific

Asia Pacific, by Product

Asia Pacific, by End-User

Asia Pacific, by Technology

Eastern Europe, by Country

Russia

Turkey

Rest of Eastern Europe

Eastern Europe, by Product

Eastern Europe, by End-User

Eastern Europe, by Technology

Middle East, by Country

UAE

Saudi Arabia

Qatar

Iran

Rest of Middle East

Middle East, by Product

Middle East, by End-User

Middle East, by Technology

Rest of the World, by Country

South America

Africa

Rest of the World, by Product

Rest of the World, by End-User

Rest of the World, by Technology

Major Companies: Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, Inc., Becton, Dickinson and Company (, DiaSorin, GFE, Trinity Biotech, Merck Millipore, GE Healthcare.

Reasons to Buy This Report:

Customization:

We provide customization of the study to meet specific requirements:

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: US +1 208 405 2835 / UK +44 121 364 6144 / APAC +91 706 672 4848

Email: [emailprotected]

Web: http://www.quincemarketinsights.com

The rest is here:
Blood screening Research, Opportunities, Emerging Trends, Competitive Strategies And Forecasts 2016-2028 - 3rd Watch News

Read More...

Insect Cell Culture MARKET SIZE BY APPLICATION, TYPES, END-USER, REGIONAL ANALYSIS AND FORECAST 2020 TO 2025 – Cole of Duty

June 13th, 2020 12:43 pm

This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by Coronavirus (COVID-19) has influenced each part of life all inclusive, including the business segment. This has brought along a several changes in economic situations.

New Study about the Insect Cell Culture Market by MRB

The new report offers a powerful combination of latest, in-depth research studies on the Insect Cell Culture market. The authors of the report are highly experienced analysts and possess deep market knowledge.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures): http://marketresearchbazaar.com/requestSample/15998

Major Players Analyzed Under This Report are:

> Life TechnologiesCorning (Cellgro)Sigma-AldrichThermo FisherMerck MilliporeGE HealthcareLonzaBDHiMediaTakaraCellGenixAtlanta BiologicalsPromoCell

Insect Cell Culture Players/Suppliers Profiles and Sales Data: Company, Company Basic Information, Manufacturing Base and Competitors, Product Category, Application and Specification with Sales, Revenue, Price and Gross Margin, Main Business/Business Overview.

Table Of Content

Market Overview: Scope & Product Overview, Classification of Insect Cell Culture by Product Category (Market Size (Sales), Market Share Comparison by Type (Product Category)), Insect Cell Culture Market by Application/End Users (Sales (Volume) and Market Share Comparison by Application), Market by Region (Market Size (Value) Comparison by Region, Status and ProspectInsect Cell Culture Market by Manufacturing Cost Analysis:Key Raw Materials Analysis, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Cost Structure (Raw Materials, Labor Cost), Manufacturing Process Analysis

Key Benefits for Stakeholders

The study provides an in-depth analysis of the Insect Cell Culture market size along with the current trends and future estimations to elucidate the imminent investment pockets.Information about key drivers, restraints, and opportunities and their impact analysis on the market size is provided.Porters five forces analysis illustrates the potency of buyers and suppliers operating in the portable gaming industry.The quantitative analysis of the Insect Cell Culture industry from 2020 to 2026 is provided to determine the Insect Cell Culture market potential.

Insect Cell Culture Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026

The research report is broken down into chapters, which are introduced by the executive summary. Its the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the Insect Cell Culture market includes Porters five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

Get Customized Report in your Inbox within 24 hours: http://marketresearchbazaar.com/enquiry/15998

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type Classical Media & SaltsSerum-free MediaStem Cell Media

Segment by Application Biopharmaceutical ManufacturingTissue Culture & EngineeringGene TherapyCytogenetic

Insect Cell Culture Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

Insect Cell Culture Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Insect Cell Culture market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2025. These analyses will help the reader to understand the potential worth of investment in a particular region.

Key Strategic Developments:The study also includes the key strategic developments of the Insect Cell Culturemarket, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features:The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, market share, CAGR, and gross margin.Analytical Tools: The Insect Cell Culture Market report includes the precisely studied and weighed data of the key industry players and their scope in the Insect Cell Culture market by means of several analytical tools

Read More Report: http://marketresearchbazaar.com/requestSample/15998

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

Market Research Bazaar

UK: +442070973908

US: +13156360953

India: +919548234540

Email: [emailprotected]

Website: http://marketresearchbazaar.com/

Blog: http://marketresearchbazaar.com/blogs

View post:
Insect Cell Culture MARKET SIZE BY APPLICATION, TYPES, END-USER, REGIONAL ANALYSIS AND FORECAST 2020 TO 2025 - Cole of Duty

Read More...

MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE : GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL – SLIDE…

June 13th, 2020 12:43 pm

06/12/2020 | 04:48pm EDT

Abstract #EP829:

Mutations in RAS pathway genes correlate with Type

of Failure to Azacitidine: Genomic Analysis at

Randomization onto the INSPIRE Trial

Koichi Takahashi, MD1, Anna Jonasova, MD, PhD2, Selina M. Luger, MD, FRCPC3, Aref Al-Kali,

MD4, David Valcrcel, MD5, Erica D. Warlick, MD6, Wieslaw W. Jedrzejczak, MD, PhD7, Mara

Dez-Campelo, MD, PhD8, Patrick S. Zbyszewski, MBA9, Christopher Cavanaugh9, Richard C.

Woodman, MD9& Steven M. Fruchtman, MD9, Guillermo Garcia-Manero, MD1

1University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX; 21st Medical Department - Hematology, General Hospital, Prague, Czech Republic; 3Abramson

Cancer Center, University of Pennsylvania, Philadelphia, PA; 4Division of Hematology, Mayo Clinic, Rochester, MN; 5Planta Baixa, Hospital Universitari Vall d'Hebron, Barcelona, Spain; 6Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN; 7MTZ Clinical Research, Medical University of Warsaw, Warsaw, Poland; 8Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain; 9Onconova Therapeutics, Inc., Newtown, PA; 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

EHA May2020

Confidential

1

Introduction

EHA May2020

Confidential

2

Eligibility:

2:1

R

A

Rigosertib + best

N

supportive care

D

N = 240

O

Primary

M

Endpoint:

I

Overall

Z

Survival

A

Physician's Choice of

(288 Events)

T

Treatment + best

I

supportive care

O

N = 120

N

Primary Objective: To compare the overall survival (OS) of patients in the rigosertib group vs PC arm in all patients and a sub-group of patients with IPSS-R very high risk;

Exploratory Objective: Correlation of overall survival and clinical responses with mutational status;

EHA May2020

Confidential

3

Key Inclusion Criteria

EHA May2020

Confidential

4

Methodology

EHA May2020

Confidential

5

Table 1: Patient Demographics (N=190)

Number of patients (%)

Sex

Female

67

(35)

Male

121 (64)

Unknown

2

(1)

Race

Asian

22

(12)

Black

3

(2)

White

152 (80)

Other

6

(3)

Unknown

7

(4)

Age (yr)

Median

73

Range

54 - 82

ECOG performance Status

0

40

(21)

1

87

(46)

2

19

(10)

Read more from the original source:
MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE : GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL - SLIDE...

Read More...

(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,…

June 13th, 2020 12:42 pm

Precision Medicine SoftwareMarket 2020: Inclusive Insight

Los Angeles, United States,June 2020:The report titled Global Precision Medicine Software Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Precision Medicine Software market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Precision Medicine Software market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Precision Medicine Software market is carefully analyzed and researched about by the market analysts.

Precision Medicine Software Market competition by top manufacturers/ Key player Profiled: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/867663

Global Precision Medicine Software Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020- 2025. According to the latest report added to the online repository of Alexareports the Precision Medicine Software market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Based on region, the globalPrecision Medicine Software market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Precision Medicine Software Market Segment by Type covers: Cloud-based, On-premise

Precision Medicine Software Market Segment by Industry: Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Others

After reading the Precision Medicine Software market report, readers get insight into:

*Major drivers and restraining factors, opportunities and challenges, and the competitive landscape*New, promising avenues in key regions*New revenue streams for all players in emerging markets*Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions*Demand and uptake patterns in key industries of the Precision Medicine Software market*New research and development projects in new technologies in key regional markets*Changing revenue share and size of key product segments during the forecast period*Technologies and business models with disruptive potential

Key questions answered in the report:

What will the market growth rate of Precision Medicine Software market?What are the key factors driving the global Precision Medicine Software market size?Who are the key manufacturers in Precision Medicine Software market space?What are the market opportunities, market risk and market overview of the Precision Medicine Softwaremarket?What are sales, revenue, and price analysis of top manufacturers of Precision Medicine Software market?Who are the distributors, traders, and dealers of Precision Medicine Software market?What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Softwareindustries?What are sales, revenue, and price analysis by types and applications of Precision Medicine Softwaremarket?What are sales, revenue, and price analysis by regions of Precision Medicine Software industries?

Get a discount on this report now at https://www.alexareports.com/check-discount/867663

Table of ContentsSection 1 Precision Medicine Software Product DefinitionSection 2 Global Precision Medicine Software Market Manufacturer Share and Market Overview2.1 Global Manufacturer Precision Medicine Software Shipments2.2 Global Manufacturer Precision Medicine Software Business Revenue2.3 Global Precision Medicine Software Market Overview2.4 COVID-19 Impact on Precision Medicine Software IndustrySection 3 Manufacturer Precision Medicine Software Business Introduction3.1 Syapse Precision Medicine Software Business Introduction3.1.1 Syapse Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.1.2 Syapse Precision Medicine Software Business Distribution by Region3.1.3 Syapse Interview Record3.1.4 Syapse Precision Medicine Software Business Profile3.1.5 Syapse Precision Medicine Software Product Specification3.2 Allscripts Precision Medicine Software Business Introduction3.2.1 Allscripts Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.2.2 Allscripts Precision Medicine Software Business Distribution by Region3.2.3 Interview Record3.2.4 Allscripts Precision Medicine Software Business Overview3.2.5 Allscripts Precision Medicine Software Product Specification3.3 Qiagen Precision Medicine Software Business Introduction3.3.1 Qiagen Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Qiagen Precision Medicine Software Business Distribution by Region3.3.3 Interview Record3.3.4 Qiagen Precision Medicine Software Business Overview3.3.5 Qiagen Precision Medicine Software Product Specification3.4 Roper Technologies Precision Medicine Software Business Introduction3.5 Fabric Genomics Precision Medicine Software Business Introduction3.6 Foundation Medicine Precision Medicine Software Business IntroductionSection 4 Global Precision Medicine Software Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Precision Medicine Software Market Size and Price Analysis 2014-20194.1.2 Canada Precision Medicine Software Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Precision Medicine Software Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Precision Medicine Software Market Size and Price Analysis 2014-20194.3.2 Japan Precision Medicine Software Market Size and Price Analysis 2014-20194.3.3 India Precision Medicine Software Market Size and Price Analysis 2014-20194.3.4 Korea Precision Medicine Software Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Precision Medicine Software Market Size and Price Analysis 2014-20194.4.2 UK Precision Medicine Software Market Size and Price Analysis 2014-20194.4.3 France Precision Medicine Software Market Size and Price Analysis 2014-20194.4.4 Italy Precision Medicine Software Market Size and Price Analysis 2014-20194.4.5 Europe Precision Medicine Software Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Precision Medicine Software Market Size and Price Analysis 2014-20194.5.2 Africa Precision Medicine Software Market Size and Price Analysis 2014-20194.5.3 GCC Precision Medicine Software Market Size and Price Analysis 2014-20194.6 Global Precision Medicine Software Market Segmentation (Region Level) Analysis 2014-20194.7 Global Precision Medicine Software Market Segmentation (Region Level) AnalysisSection 5 Global Precision Medicine Software Market Segmentation (Product Type Level)5.1 Global Precision Medicine Software Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Precision Medicine Software Product Type Price 2014-20195.3 Global Precision Medicine Software Market Segmentation (Product Type Level) AnalysisSection 6 Global Precision Medicine Software Market Segmentation (Industry Level)6.1 Global Precision Medicine Software Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Precision Medicine Software Market Segmentation (Industry Level) AnalysisSection 7 Global Precision Medicine Software Market Segmentation (Channel Level)7.1 Global Precision Medicine Software Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Precision Medicine Software Market Segmentation (Channel Level) AnalysisSection 8 Precision Medicine Software Market Forecast 2019-20248.1 Precision Medicine Software Segmentation Market Forecast (Region Level)8.2 Precision Medicine Software Segmentation Market Forecast (Product Type Level)8.3 Precision Medicine Software Segmentation Market Forecast (Industry Level)8.4 Precision Medicine Software Segmentation Market Forecast (Channel Level)Section 9 Precision Medicine Software Segmentation Product Type9.1 Cloud-based Product Introduction9.2 On-premise Product IntroductionSection 10 Precision Medicine Software Segmentation Industry10.1 Healthcare Providers Clients10.2 Pharmaceutical and Biotechnology Companies Clients10.3 Research Centers and Government Institutes Clients10.4 Others ClientsSection 11 Precision Medicine Software Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/867663

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Read this article:
(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,...

Read More...

Precision Medicine Software Market Breaking New Grounds and Touch new Level in Upcoming Year by Syapse, Allscripts, Qiagen, Roper Technologies, Fabric…

June 13th, 2020 12:42 pm

Precision Medicine Software Market report focused on the comprehensive analysis of current and future prospects of the Precision Medicine Software industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Precision Medicine Software market has been done in order to calculate the growth rates for each segment and sub-segments.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=79150

Top Key Vendors of this Market are:

Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Lifeomic Health.

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Precision Medicine Software market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Precision Medicine Software markets trajectory between forecast periods.

The report provides insights on the following pointers:

Market Penetration:Comprehensive information on the product portfolios of the top players in the Precision Medicine Software market.

Product Development/Innovation:Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development:Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments in the Precision Medicine Software market.

Hurry Up! Get Upto 25% Discount on this Report @:

https://www.a2zmarketresearch.com/discount?reportId=79150

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Precision Medicine Software market. It focuses on the major points, which are necessary to make positive impacts on the market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

Table of Contents

Global Precision Medicine Software Market Research Report 2020 2026

Chapter 1 Precision Medicine Software Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Precision Medicine Software Market Forecast

For more Information, Inquire @:

https://www.a2zmarketresearch.com/enquiry?reportId=79150

If you have any special requirements, please let us know and we will offer you the report as you want.

Read the original here:
Precision Medicine Software Market Breaking New Grounds and Touch new Level in Upcoming Year by Syapse, Allscripts, Qiagen, Roper Technologies, Fabric...

Read More...

Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC – OncLive

June 12th, 2020 3:50 am

Jean Lopategui, MD, discusses the evolution of targeted therapies in nonsmall cell lung cancer.

Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the evolution of targeted therapies in nonsmall cell lung cancer (NSCLC).

Ten years ago, not many targeted therapies were available in the field, but there has been a tremendous improvement in the treatment of patients with NSCLC, says Lopategui. The 1-year mortality rate of stage IV NSCLC is about 50%. Today, patients who harbor molecular alterations can experience durable remissions due to the development of targeted therapies.

Additionally, checkpoint inhibitors could be a second-line treatment option after disease progression on targeted therapies or chemotherapy. These agents could further extend the lives of patients with NSCLC. Although these agents are not curative, it is encouraging to see the progress that has been made, concludes Lopategui.

Original post:
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC - OncLive

Read More...

Renaissance Academy Class of 2020 Graduates with Over $17 Million in Scholarships – MyChesCo

June 12th, 2020 3:50 am

PHOENIXVILLE, PA On Wednesday, June 10th, 2020, seventy-three seniors graduated from the Renaissance Academy Charter School (RA). The ceremony was held at 7:00 pm and included all the RA traditional Commencement Ceremony through video. The event featured Keynote Speaker and Valedictorian speeches, various awards and scholarships presentations, as well as, the seniors being announced and recognized for earning their diplomas

The keynote speaker, selected by student vote, was Kelly Najdawi, the K-12 Curriculum Leader of English Language Arts at RA. Born and raised in Radnor, PA, Mrs. Najdawi graduated Magna Cum Laude from West Chester University in 2008, earning a Bachelor of Science in Education with a Middle School English Language Arts Certification. She began working at RA in 2008.

During her eleven-year career at RA, Mrs. Najdawi taught English Language Arts to this graduating class in both their 7th and 8th grade years. As their teacher, she made a special connection with this class and is confident they will go on to make a real difference in the world. This class has always impressed me with their academic drive, personal voice, and understanding, so I felt they were already best prepared to take on their future. I trust them and the decisions they are going to make and expect them to positively change the status quo by using everything Renaissance has instilled in them.

Also speaking at the ceremony was Carolyn (Carly) Higgins, 2020 Valedictorian. As Carly reflected back on her time at RA, she spoke of the challenges her class faced together as a unified group. She went on to stress the importance of self-dependency and having the bravery to pursue life goals even when there are powerful obstacles ahead. We have the ability to make our dreams a reality, but you have to have the courage to trust yourself first. Thats the world that I want to live in and I know you do too.

In the fall, Carly plans to be on the pre-med track with a dual major in biology and molecular genetics. While she has not yet decided on her specific college, Carly has been accepted to the Rochester Institute of Technologys Physicians Assistant Program (BS/MS) 5 year program, the University of Rochesters biological sciences program in molecular genetics, the University of Richmond; the University of Hawaii at Mnoa, and West Chester University of Pennsylvanias biology-cell and molecular program.

The RA 2020 Salutatorian, Jeremy Wenger, who will be attending Olin College of Engineering located in Needham, Massachusetts, gave his speech during a graduation achievement and awards event on Monday night. Jeremy spoke about the accomplishments and unity of his graduating class, as well as their ability to change the world with what they know is true. Now it is our time to shape the world. We just need to be brave enough to do it.

The Renaissance Academy Charter School graduating class of 2020 includes:Grace Katherine Abendshein (Phoenixville, PA), Jamod O. Adams (Norristown, PA), Mark D. Adams (Royersford, PA), Olivia Elizabeth Andreoni (Eagleville, PA), Joshua David BarrancoSilva (Phoenixville, PA), Daniel Eric Barron (Coatesville, PA), Naomi Michele Bruno (Sanatoga, PA), Gavin Daniel Budniak (West Norriton, PA), Olivia Rose Campbell (Royersford, PA), Giavanna M. Caperila (Phoenixville, PA), Emily Paige Cassidy (Phoenixville, PA), Alyssa N. Cekic (Phoenixville, PA), Brianna Chandler (Norristown, PA), Shaun Maria Chester (Phoenixville, PA), Jahi Peter Clark (Norristown, PA), Gabriel Avery Cole (Pottstown, PA), Geoffrey James Cross Jr. (Pottstown, PA), Emilia Anna Crow (Royersford, PA), Susannah Jeannette Cushmore (Norristown, PA), Cornelius I. Dairo (Norristown, PA), Taylor Lynn Darden (Phoenixville, PA), Gianna Rose Debro (Royersford, PA), Jonathan William DeSanto (Phoenixville, PA), Kayla Nicole Diaz (Norristown, PA), Samuel Miles Dooling (Norristown, PA), Ryan James Dunn (Phoenixville, PA) Olivia Rachel Ferst (Norristown, PA), Nicolette G. Foster (East Norriston, PA), Madison Elizabeth Francis (Pottstown, PA), Avinash Suhas Ganguly (Jeffersonville, PA), Kelly Roberta Garman (Collegeville, PA), Morgan Elizabeth Gidney (Gilbertsville, PA), Jaeshon Goodman-Rhodes (Norristown, PA), Grace Riley Grenier (Jeffersonville, PA), Kathryn Ann Guevin (Phoenixville, PA), Shay S. Gustafson (Collegeville, PA), Kiley Rae Henderson (Pottstown, PA), Carolyn S. Higgins (Morgantown, PA), Kaitlin Bryn Irby (Phoenixville, PA), Majesty Sanai Jerry (Norristown, PA), Jurnee Ann Jessie (Norristown, PA), Adam Christopher Johnson (Norristown, PA), Micaiah Allen Jones (Norristown, PA), Elisabeth Faith Kerper (Jeffersonville, PA), Theresa Rose Kolter (Phoenixville, PA), Malachy L. Lacy (Jeffersonville, PA), Tyler Anthony Magyar (Pottstown, PA), Grace Elizabeth Moreschi (Audubon, PA) Lindsey Nicole ODonnell (Norristown, PA), Max Victor Olstad (Phoenixville, PA), Angelina Clair Pagano (Pottstown, PA), Dominique Xandria Parrish-Hankins (Norristown, PA), James Joseph Pritz IV (East Norriston, PA), Aliyah Nicole Quill (Phoenixville, PA), Benjamin Ali-Reza Rabizadeh (Exton, PA), Erin Kathleen Robbins (Collegeville, PA), Tyler Steven Robbins (Jeffersonville, PA), Trevor Mitchell Schmidt (East Norriton, PA), Lily Catherine Shaffer (Collegeville, PA), Paige Kimberly Simon (Norristown, PA), Lauren R. Stauch (Phoenixville, PA), Sara Bernadette Stockett (Norristown, PA), Lanasha Sweeper (East Norriton, PA), Nathen Lim Te (Norristown, PA), Devon Lynn Testa (Phoenixville, PA), Sarah Irene Trexler (Spring City, PA), Nissi Jayanth Vinnakota (Norristown, PA), Dominique Meghan Vinson (Conshohocken, PA), Alexander Joseph Waskiewicz (Norristown, PA), Cassandra Jean Waskiewicz (Norristown, PA), Jeremy Benjamin Wenger (Royersford, PA), Chandler D. White (Norristown, PA), and Cole Raymond Winters (Phoenixville, PA).

These graduates have been accepted to universities such as Rensselaer Polytechnic Institute, Dickinson College, Boston University, Bucknell University, University of Rochester, Ohio State University, Olin College of Engineering, University of Michigan, American University, George Washington University, and Swarthmore College. They have been collectively offered (to date) a scholarship total of $17,101,514.00, a new Renaissance Academy merit scholarship school record. Tracey Behrens OBrien, RA Academic and College Counselor noted that nearly all of the scholarships have been awarded to the students by the individual universities, not from scholarship search sites. It is so exciting to see an unprecedented number of students in the Class of 2020 being recognized by prestigious colleges.

Due to the current COVID-19 conditions, some of the traditional RA end-of-year senior events were held a little differently. The graduates were celebrated over five unique nights. Each night, a different link was released on the Senior Knights 2020 website. The nights had videos and live feeds with different focuses including a night for athletics and the arts; a senior class photo slideshow night; awards and the Salutatorian speech; the senior parent reveal night; the 2020 commencement ceremony; and finally, the graduates processional parade.

About this special group of graduates, Upper School Principal, Michelle Boyd said, The Class of 2020 will always stand out for all that they have gone through and how they have persevered through such challenging times. The Class of 2o20 displays true grit and determinationthey will surely go on to change the world for the better!

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Originally posted here:
Renaissance Academy Class of 2020 Graduates with Over $17 Million in Scholarships - MyChesCo

Read More...

Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases…

June 12th, 2020 3:50 am

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced a strategic research collaboration with Columbia University Irving Medical Center researchers (Columbia) to advance genetic based therapies for a range of rare neurological conditions, complementary to Ovids current pipeline. This collaboration provides Ovid with the potential to expand its future drug development portfolio and impact individuals living with rare genetic neurological conditions.

Under this research and translational development alliance, Columbia will align its expertise in rare disease genetics and deep clinical understanding of rare neurological diseases with Ovids discovery, translational, and clinical development expertise in neurodevelopmental disorders and rare epilepsies. Ovid will work closely with Wendy K. Chung, M.D., Ph.D., the Chief of Clinical Genetics, and leader of the Precision Medicine Resource in the Irving Institute at Columbia University Irving Medical Center. Dr. Chung is a recognized genetics leader with over 20 years of experience in human genetic research of monogenic and complex traits, mapping and cloning genes in humans, and describing the clinical characteristics and natural history of novel genetic conditions. A 2019 National Organization for Rare Disorders (NORD) Rare Impact Award Honoree, Dr. Chung is also a leader and advocate within the rare disease patient community.

Under the collaboration, Ovid will work together with Columbia scientists to identify molecular targets for developing genetic/molecular therapeutic approaches for rare neurological conditions such as KIF1A-associated neurological disorder (KAND) and other rare conditions.

Ovid has made significant progress in all its late stage clinical programs. We are excited to see multiple read outs of clinical data throughout the year. Its time to begin to build our pipeline for our long-term future in a disciplined and strategic fashion. This next step is built on, and will complement, the important programs we already have in place, said Amit Rakhit, M.D., MBA, President and Chief Medical Officer of Ovid Therapeutics. Joining forces with Columbia and Dr. Chung, a world-class clinical geneticist, will enable Ovid to begin to build a robust gene and molecular therapy platform for the future treatment of inherited neurological conditions.

My laboratory is committed to discovering innovative new targets and therapies to address rare neurological diseases with few or no treatment options, said Dr. Chung. This alliance is further evidence of Columbias unwavering commitment to enabling groundbreaking research and developing cutting-edge technologies to treat neurological conditions. We are excited to partner with Ovid and the patient community to help advance these programs into clinical trials for development of new potential therapies.

About Ovid TherapeuticsOvid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The Companys most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE). For more information on Ovid, please visit http://www.ovidrx.com/.

Forward-Looking Statements This press release includes certain disclosures that contain forward-looking statements, including, without limitation, statements regarding: advancing and commercializing Ovids product candidates, progress, timing, scope and thedevelopment andpotential benefitsofOvids product candidates; and the anticipated reporting schedule of clinical data regarding Ovids product candidates. You can identify forward-looking statements because they contain words such as will,appears,believes and expects. Forward-looking statements are based on Ovids current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements includeuncertainties in the development and regulatory approval processes,andthe fact that initial data from clinical trials may not be indicative, and are not guarantees, of the final results of the clinical trials and are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and/or more patient data become available. Additional risks that could cause actual results to differ materially from those in the forward-looking statements are set forth in Ovids filings with theSecurities and Exchange Commissionunder the caption Risk Factors.Such risks may be amplified by the COVID-19 pandemicand its potential impact on Ovids businessand theglobal economy.Ovid assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Contacts

Investors and Media:Ovid Therapeutics Inc.Investor Relations & Public Relationsirpr@ovidrx.com

Or

Investors: Steve KlassBurns McClellan, Inc.sklass@burnsmc.com (212) 213-0006

Media:Katie Engleman1ABkatie@1abmedia.com(919) 333-7722

Link:
Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases...

Read More...

Outlook on the United States Solid Tumor Testing Industry to 2030 – Analysis and Forecast – GlobeNewswire

June 12th, 2020 3:50 am

Dublin, June 08, 2020 (GLOBE NEWSWIRE) -- The "U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Biomarker Type, Application, End User, State Region, and Competitive Landscape - Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

According to this market intelligence report titled the U.S. solid tumor testing market was valued at $8,179.7 million in 2019 and is anticipated to grow over $15,396.4 million by 2030. The U.S. solid tumor testing market is expected to grow at a single-digit compound annual growth rate in the forecast period 2020-2030, aided primarily by the high growth in the molecular diagnostics market.

The term solid tumor refers to abnormal cellular growths, which generally comprise sarcomas, carcinomas, and lymphomas. The current solid tumor testing market is mainly dominated by several diagnostic majors, such as Quest Diagnostics Incorporated, Laboratory Corporation of America, Foundation Medicine, which offer a wide variety of testing services for solid tumors. These testing services range from molecular-genetic tests to liquid biopsies for the confirmatory diagnosis of solid tumors. The key players in the product segment include Illumina, Abbott Laboratories, and ThermoFisher Scientific, which offer kits for the analysis of solid tumors.

The solid tumor tests are generally based on technologies such as fluorescence in situ hybridization (FISH), immunohistochemistry (INC), bi-directional sanger sequencing, polymerase chain reaction (PCR), next-generation sequencing (NGS), and other technologies. The underlying utility of diagnostic testing for solid tumors is based on the identification of clinically actionable gene mutations, which provide crucial information on diagnosis, prognosis, and theranosis of solid tumors and thereby facilitate clinical work-up, treatment management, and therapeutic selection.

The existing market of solid tumor testing is favored by multiple factors, which include rising government initiatives, increasing incidence of cancer, thereby increasing the utilization of testing technologies to identify the underlying mutations. In addition, an increasing number of product approvals and launches pertaining to U.S. solid tumor testing market will provide a lucrative growth for this market. Moreover, increasing the use of biomarkers in cancer profiling is also one of the key driving factors for the solid tumor testing market.

Government funding is also one of the major growth factors for the solid tumor testing market because increasing funding by the government is expected to facilitate research institutes and key players to develop as well as market novel assays useful for the diagnosis of several tumors. Increasing funding will lead to the liquidity of the solid tumor market, and thus, companies will develop various testing options for solid tumors to identify the underlying mutations that serve as a possible cause for the disease. All these factors are therefore expected to contribute to the market growth during the forecast period.

Within the research report, the market is segmented on the basis of product type, technology, application, end user, cancer type, biomarker type, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises state-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-degree coverage of the domain.

This report is a meticulous compilation of research on more than 30 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The report also comprises 15 detailed company profiles including several key players, such as Abbott Laboratories, Laboratory Corporation of America, Quest Diagnostics Incorporated, Illumina, F. Hoffmann-La Roche, ARUP Laboratories, Bio-Rad Laboratories, Inc., Asuragen Inc., Cancer Genetics Inc., Invitae Corporation, NeoGenomics Laboratories, Inc., and QIAGEN N.V.

Key trends targeted in the report:

Key Topics Covered:

1 Product Definition1.1 Inclusion and Exclusion

2 Market Scope2.1 Scope of Work2.2 Key Questions Answered in the Report

3 Research Methodology3.1 U.S. Solid Tumors Testing Market: Research Methodology3.2 Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model3.5 Criteria for Company Profiling

4 Market Overview4.1 Definition4.2 Solid Tumor Testing Technologies4.3 Market Size and Growth Potential, $Million, 2019-20304.4 Industry Participants Landscape

5 Epidemiology of Solid Tumors in U.S.

6 Industry Insights6.1 Regulation of Genetic Tests6.1.1 FDA Regulation6.1.2 CMS Regulation6.2 Reimbursement Scenario6.2.1 Impact on Laboratory Industry

7 Market Dynamics7.1 Market Drivers7.1.1 Rising Incidence of Cancers7.1.2 Decreasing Cost of Sequencing7.1.3 Increasing Adoption of Inorganic Growth Strategies in the Market7.1.4 Increasing Research Funding from the National Cancer Institute7.1.5 Expected Increase in Adoption of Genetic Testing7.2 Restraints7.2.1 Reimbursement Cuts in the U.S.7.2.2 Expected Implementation of the Patient Protection and Affordable Care Act in the U.S.7.2.3 High Pricing Pressure7.3 U.S. Market Opportunities7.3.1 Informatics and Technological Innovation for Larger Consumer Base7.3.2 Mushrooming Direct-to-Consumer (DTC) Testing Services Market

8 Competitive Landscape8.1 Key Strategies and Developments8.1.1 Synergistic Activities8.1.2 Approvals8.1.3 Product Launches, Enhancements, and Expansion8.1.4 Acquisitions and Mergers8.2 Product Scenario8.3 Funding Scenario8.4 Market Share Analysis8.5 Growth Share Analysis (Opportunity Mapping)8.5.1 By Company8.5.2 By Technology8.5.3 By Application8.5.4 By Cancer Type

9 U.S. Solid Tumor Testing Market (by Technology)9.1 Overview9.2 Next-Generation Sequencing9.3 In Situ Hybridization9.4 Polymerase Chain Reaction9.5 Immunohistochemistry9.6 Other Technologies

10 U.S. Solid Tumor Testing Market (by Cancer Type)10.1 Overview10.2 Breast Cancer10.3 Prostate Cancer10.4 Colorectal Cancer10.5 Lung Cancer10.6 Melanoma10.7 Endometrial Cancer10.8 Thyroid Cancer10.9 Brain Cancer10.10 Ovarian Cancer10.11 Liver Cancer10.12 Other Cancer Types

11 U.S. Solid Tumor Testing Market (by Type of Biomarker)11.1 Overview11.2 Genetic Biomarkers11.3 Protein Biomarkers11.4 Other Biomarkers

12 U.S. Solid Tumor Testing Market (by Application)12.1 Overview12.2 Clinical12.3 Research

13 U.S. Solid Tumor Testing Market (by End User)13.1 Overview13.2 Hospitals, Diagnostic Laboratories, and Reference Laboratories13.3 Pharmaceutical and Biotechnology Companies13.4 Contract Research Organizations13.5 Academic Research Institutions13.6 Other End Users

14 U.S. Solid Tumor Testing Market (by State Region)14.1 Overview14.2 The South U.S.14.3 The Midwest U.S.14.4 The Mid-Atlantic U.S.14.5 The West U.S.14.6 The Southwest U.S.14.7 New England

15 Company Profiles15.1 Overview15.2 Abbott Laboratories15.2.1 Company Overview15.2.2 Role of Abbott Laboratories in the U.S. Solid Tumor Testing Market15.2.3 Financials15.2.4 Key Insights About Financial Health of the Company15.2.5 SWOT Analysis15.3 Illumina, Inc.15.4 F. Hoffmann-La Roche Ltd.15.5 Bio-Rad Laboratories, Inc.15.6 ASURAGEN, INC.15.7 Cancer Genetics Inc.15.8 QIAGEN N.V.*15.9 Quest Diagnostics Incorporated15.10 ARUP Laboratories15.11 Invivoscribe, Inc.15.12 NeoGenomics Laboratories, Inc.15.13 Invitae Corporation15.14 Opko Health15.15 Laboratory Corporation of America Holdings15.16 OmniSeq15.17 Nanostring Technologies15.18 Guardant Health15.19 Personal Genome Diagnostics15.20 HTG Molecular Diagnostics15.21 Caris Life Sciences15.22 Genomic Testing Cooperative15.23 ArcherDX, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/wer8j9

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Continue reading here:
Outlook on the United States Solid Tumor Testing Industry to 2030 - Analysis and Forecast - GlobeNewswire

Read More...

Exercise Alters Molecules In The Blood – Anti Aging News

June 12th, 2020 3:50 am

According to a recent study published in PubMed a single session of exercise alters 9,815 of the 17,662 different molecules in our blood that were measured in this study, with the types of molecules widely ranging and some being involved in fueling, metabolism, immune responses, tissue repair, or appetite. Within those categories the molecular courses changed within an hour with those that increase inflammation surging early than dropping to be replaced with those more likely to help reduce inflammation.

It was like a symphony, says Michael Snyder, the chair of the genetics department at Stanford University and senior author of the study. First you have the brass section coming in, then the strings, then all the sections joining in.

This study is suggested to be the most comprehensive catalog to date of the molecular changes that occur during and after exercise that highlights how consequential activity/inactivity may be for the human body and health.

Different peoples blood follows different orchestrations; those showing signs of insulin resistance for example tended to show smaller increases in some of the molecules related to healthy blood sugar control and higher increases in molecules involved in inflammation, suggesting that they may be somewhat resistant to the general beneficial effects of exercise. Additionally, depending on the individuals current aerobic fitness levels of other molecules ranged considerably.

Overall the researchers were surprised by their findings regarding what they were observing in the changes in molecular profiles after exercise: I had thought, its only about nine minutes of exercise, how much is going to change? A lot, as it turns out. said Dr. Snyder.

However, this study was not without its limitations such as being a small study that only included participants over the age of 40, and it only looked at a single session of aerobic exercise, as such this study cant tell us anything about the longer term molecular effects of continued training or of how the changes in molecular levels may subsequently alter health.

The research team will be conducting follow up studies with more participants and sustained exercise routines, hoping to establish whether certain molecular responses to exercise may be able to distinguish those who might benefit from emphasizing resistance exercises over endurance training, and whether specific molecular profiles can indicate who has higher/lower aerobic endurance. Such answers may provide information that could allow physicians and researchers alike to check for fitness with a blood sample rather than treadmill stress testing.

See the original post here:
Exercise Alters Molecules In The Blood - Anti Aging News

Read More...

Page 529«..1020..528529530531..540550..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick